|
27 Mar 2020 |
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
|
|
26 Mar 2020 |
INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
|
|
26 Mar 2020 |
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
|
|
26 Mar 2020 |
Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
|
|
26 Mar 2020 |
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
|
|
25 Mar 2020 |
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
|
|
25 Mar 2020 |
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
|
|
24 Mar 2020 |
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
|
|
24 Mar 2020 |
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
|
|
24 Mar 2020 |
Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
|
|
24 Mar 2020 |
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
|
|
23 Mar 2020 |
Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
|
|
23 Mar 2020 |
COVID-19 vaccine development
|
|
23 Mar 2020 |
Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
|
|
19 Mar 2020 |
SELLAS Announces Positive Antigen-Specific Immune Response Data for Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast from Phase 2 VADIS Study
|
|
19 Mar 2020 |
Versatope Selects Influenza Vaccine Candidate for Clinical Development
|
|
19 Mar 2020 |
Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform
|
|
19 Mar 2020 |
Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older
|
|
17 Mar 2020 |
Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
17 Mar 2020 |
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
|
|
16 Mar 2020 |
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
|
|
15 Mar 2020 |
Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
|
|
13 Mar 2020 |
Medicago Announces Production of a Viable Vaccine Candidate for COVID-19
|
|
12 Mar 2020 |
Virometix Announces Initiation of Phase 1 Clinical Trial With Its V-306 Vaccine Candidate
|
|
11 Mar 2020 |
Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
|
